Clinical significance of serum-derived exosomal PD-L1 expression in patients with advanced pancreatic cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Clinical significance of serum-derived exosomal PD-L1 expression in patients with advanced pancreatic cancer ; volume:23 ; number:1 ; day:1 ; month:5 ; year:2023 ; pages:1-10 ; date:12.2023
BMC cancer ; 23, Heft 1 (1.5.2023), 1-10, 12.2023
- Creator
-
Park, Se Jun
Park, Ju Yeon
Shin, Kabsoo
Hong, Tae Ho
Lee, MyungAh
Kim, Younghoon
Kim, In-Ho
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-023-10811-8
- URN
-
urn:nbn:de:101:1-2023090511044757347445
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Park, Se Jun
- Park, Ju Yeon
- Shin, Kabsoo
- Hong, Tae Ho
- Lee, MyungAh
- Kim, Younghoon
- Kim, In-Ho
- SpringerLink (Online service)
Other Objects (12)
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
The role of exosomal PD-L1 in tumor progression and immunotherapy
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
LAMTOR1 decreased exosomal PD-L1 to enhance immunotherapy efficacy in non-small cell lung cancer
The expansion of MDSCs induced by exosomal PD-L1 promotes the progression of gastric cancer
PD-L1 expression and the prognostic significance in gastric cancer: a retrospective comparison of three PD-L1 antibody clones (SP142, 28–8 and E1L3N)
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
The role of exosomal PD-L1 in tumor progression and immunotherapy
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
LAMTOR1 decreased exosomal PD-L1 to enhance immunotherapy efficacy in non-small cell lung cancer
The expansion of MDSCs induced by exosomal PD-L1 promotes the progression of gastric cancer
PD-L1 expression and the prognostic significance in gastric cancer: a retrospective comparison of three PD-L1 antibody clones (SP142, 28–8 and E1L3N)
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
The role of exosomal PD-L1 in tumor progression and immunotherapy
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
LAMTOR1 decreased exosomal PD-L1 to enhance immunotherapy efficacy in non-small cell lung cancer
The expansion of MDSCs induced by exosomal PD-L1 promotes the progression of gastric cancer
PD-L1 expression and the prognostic significance in gastric cancer: a retrospective comparison of three PD-L1 antibody clones (SP142, 28–8 and E1L3N)